Orbenin EDC, 600 mg intramammaarsuspensioon veistele
Orbenin EDC, 600 mg intramammaarsuspensioon veistele
Authorised
- Cloxacillin
Product identification
Medicine name:
Orbenin EDC, 600 mg intramammaarsuspensioon veistele
Active substance:
- Cloxacillin
Target species:
-
Cattle (dairy cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin600.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dairy cow)
-
Meat and offal28dayRavi ajal loomi inimtoiduks tappa ei tohi. Loomi võib inimtoiduks tappa 28 päeva pärast ravimi manustamist.
-
Milk96hourMitte kasutada lehmadel, kelle kinnisjärgu pikkus on 42 päeva või vähem. Piima võib inimtoiduks kasutada 96 tundi pärast poegimist (kaks korda päevas lüpsmise puhul 8. lüpsikorral). Kui lehm poegib varem kui 42 päeva pärast ravimi manustamist, võib piima inimtoiduks kasutada 42 päeva pluss 96 tundi pärast ravimi manustamist.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Available in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1386
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 16/09/2024
